期刊文献+

乳腺癌化疗后前哨淋巴结活检术的临床探讨 被引量:1

Clinical study of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
原文传递
导出
摘要 目的探讨乳腺癌化疗后前哨淋巴结活检术(SLNB)的准确性及临床意义。方法用美蓝作为示踪剂,对90例临床分期为Ⅱ、Ⅲ期,并已行化疗后临床检查腋窝淋巴结阴性的乳腺癌患者进行SLNB,术中均同时行腋窝淋巴结清扫术。结果90例中前哨淋巴结成功检出82例,检出率91.1%,每例检出前哨淋巴结的数量为1~4枚,平均1.6枚。82例前哨淋巴结成功检出的患者中,45例患者有腋窝淋巴结转移,其中前哨淋巴结有转移者40例,前哨淋巴结未发现转移而非前哨淋巴结有转移者5例,8例只有前哨淋巴结为阳性淋巴结,前哨淋巴结预测腋窝淋巴结状态准确率为93.9%(77/82),灵敏度为88.9%(40/45),阳性预测值为100%,阴性预测值为88.1%,假阴性率为11.1%(5/45)。原发肿瘤为T2、T3/T4组检出率分别为96.1% (49/51)、84.6%(33/39);假阴性率分别为5.3%(1/19)、15.4%(4/26),差异无统计学意义。肿瘤对化疗反应为完全缓解(CR)、部分缓解(PR)、稳定(SD)的前哨淋巴结检出率分别为92.3%、93。1%、84.2%,差异无统计学意义;假阴性5例均发生在PR、SD患者。结论化疗后腋窝淋巴结阴性的Ⅱ、Ⅲ期乳腺癌患者,行SLNB可获得与早期未行新辅助化疗乳腺癌SLNB相似的结果;化疗前原发肿瘤为T2的乳腺癌患者,SLNB能较准确预测腋窝淋巴结的状态。 Objective To study the accuracy and the clinical significance of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy for breast cancer. Methods A total of 90 patients with Stage Ⅱ or Ⅲ breast cancer and negative axillary node after neoadjuvant chemotherapy were enrolled in the study. Mapping procedure and SLNB were performed using methylene blue injected at the site of the primary breast cancer, followed by the axillary lymph node dissection. Results The sentinel lymph node(SLN) was successfully identified in 82 out of 90 patients.(91.1% ). The number of sentinel harvested nodes ranged from 1 to 4(average 1.6). The accuracy of SLNB to predict the axillary lymph node status was 93.9 % (77/82),the sensitivity, positive predictive value,negative predictive value and false negative rate were 87.5 % (40/45), 100 % , 88.1% and 11.1% (5/45 ), respectively, The SLN identification rate tended to be higher and false negative rate tended to be lower in patients with T2 primary tumor before neoadjuvant chemotherapy. Conclusion Our study indicated that SLNB after neoadjuvant chemotherapy in patients with Stage Ⅱ or Ⅲ breast cancer had a similar effect as SLNB in non-neoadjuvant studies. SLNB was considered to be able to accurately predict the axillary lymph node status in patients with T2 primary tumor before neoadjuvant chemotherapy.
出处 《中国基层医药》 CAS 2007年第10期1636-1637,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 乳腺肿瘤 药物疗法 淋巴结 Breast neoplasms Drug therapy Sentinel lymph node biopsy
  • 相关文献

参考文献3

  • 1Schwartz GF, Giuliano AE, Veronesi U, et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Cancer, 2002,94 ( 10 ) :2542-2551.
  • 2Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol, 2002,9(3) :235-242.
  • 3Shimazu K, Tamaki Y, Taguchi T, et al. Sentinel lymph node biopsy using perlareolar injection of radiocolloid for patient with neoadjuvant chemotherapy-treated breast carcinoma. Cancer, 2004, 100 (12): 2555-2561.

同被引文献17

  • 1孙淑明,林小红,汤衍斌,吴丽娥,卢晓峰.乳腺癌保乳术及前哨淋巴结活检术18例报告[J].中国基层医药,2007,14(1):78-79. 被引量:9
  • 2牛献勇,王玉虎.乳腺癌术中美蓝染色法腋窝前哨淋巴结活检及临床意义[J].中国综合临床,2007,23(6):562-562. 被引量:3
  • 3Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet, 1974,138 (3) :370-376.
  • 4Somers RG, Jablon LK, Kaplan M J, et al. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. Ann Surg, 1992, 215(2) :146-149.
  • 5Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer, 1998,83 ( 12 Suppl American) :2776-2781.
  • 6Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol, 1993,11 (8) : 1536-1544.
  • 7Dewachter P, Mouton-Faivre C, Benhaijoub A, et al. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand, 2006,50(2) :245-247.
  • 8Thevarajah S, Huston TL, Simmons RM. A comparison ofthead- verse reactions associated with isosulfan blue versus methylene blue dyein sentinel lymph node biopsy for breast cancer. Am J Surg, 2005,189(2) :236-239.
  • 9Eldrageely K, Vargas MP, Khalkhali I, et al. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracercompared to isosulfan blue. Am Surg, 2004,70 ( 10 ) : 872- 875.
  • 10Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coil Surg, 2001,192(6):684- 691.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部